Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

In vitro and in vivo evaluation of Alexa Fluor 680-bombesin[7-14]NH2 peptide conjugate, a high-affinity fluorescent probe with high selectivity for the gastrin-releasing peptide receptor.

Ma L, Yu P, Veerendra B, Rold TL, Retzloff L, Prasanphanich A, Sieckman G, Hoffman TJ, Volkert WA, Smith CJ.

Mol Imaging. 2007 May-Jun;6(3):171-80.

PMID:
17532883
[PubMed - indexed for MEDLINE]
2.

Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14).

Biddlecombe GB, Rogers BE, de Visser M, Parry JJ, de Jong M, Erion JL, Lewis JS.

Bioconjug Chem. 2007 May-Jun;18(3):724-30. Epub 2007 Mar 23.

PMID:
17378600
[PubMed - indexed for MEDLINE]
3.

Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours.

de Visser M, Bernard HF, Erion JL, Schmidt MA, Srinivasan A, Waser B, Reubi JC, Krenning EP, de Jong M.

Eur J Nucl Med Mol Imaging. 2007 Aug;34(8):1228-38. Epub 2007 Feb 8.

PMID:
17287960
[PubMed - indexed for MEDLINE]
4.

Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours.

Ferro-Flores G, Arteaga de Murphy C, Rodriguez-Cortés J, Pedraza-López M, Ramírez-Iglesias MT.

Nucl Med Commun. 2006 Apr;27(4):371-6.

PMID:
16531924
[PubMed - indexed for MEDLINE]
5.

Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes.

Smith CJ, Volkert WA, Hoffman TJ.

Nucl Med Biol. 2005 Oct;32(7):733-40. Review.

PMID:
16243649
[PubMed - indexed for MEDLINE]
6.

Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update.

Smith CJ, Volkert WA, Hoffman TJ.

Nucl Med Biol. 2003 Nov;30(8):861-8. Review.

PMID:
14698790
[PubMed - indexed for MEDLINE]
7.

[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging.

Nock B, Nikolopoulou A, Chiotellis E, Loudos G, Maintas D, Reubi JC, Maina T.

Eur J Nucl Med Mol Imaging. 2003 Feb;30(2):247-58. Epub 2002 Nov 29.

PMID:
12552343
[PubMed - indexed for MEDLINE]
8.

Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties.

Smith CJ, Gali H, Sieckman GL, Higginbotham C, Volkert WA, Hoffman TJ.

Bioconjug Chem. 2003 Jan-Feb;14(1):93-102.

PMID:
12526698
[PubMed - indexed for MEDLINE]
9.

Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.

Breeman WA, de Jong M, Erion JL, Bugaj JE, Srinivasan A, Bernard BF, Kwekkeboom DJ, Visser TJ, Krenning EP.

J Nucl Med. 2002 Dec;43(12):1650-6.

PMID:
12468515
[PubMed - indexed for MEDLINE]
Free Article
10.

Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).

Reubi JC, Wenger S, Schmuckli-Maurer J, Schaer JC, Gugger M.

Clin Cancer Res. 2002 Apr;8(4):1139-46.

PMID:
11948125
[PubMed - indexed for MEDLINE]
Free Article
11.

Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy.

Breeman WA, De Jong M, Bernard BF, Kwekkeboom DJ, Srinivasan A, van der Pluijm ME, Hofland LJ, Visser TJ, Krenning EP.

Int J Cancer. 1999 Nov 26;83(5):657-63.

PMID:
10521803
[PubMed - indexed for MEDLINE]
12.

Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy.

Breeman WA, Hofland LJ, de Jong M, Bernard BF, Srinivasan A, Kwekkeboom DJ, Visser TJ, Krenning EP.

Int J Cancer. 1999 May 17;81(4):658-65.

PMID:
10225459
[PubMed - indexed for MEDLINE]
13.

Expression and characterization of cloned human bombesin receptors.

Benya RV, Kusui T, Pradhan TK, Battey JF, Jensen RT.

Mol Pharmacol. 1995 Jan;47(1):10-20.

PMID:
7838118
[PubMed - indexed for MEDLINE]
14.

Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes.

Mantey S, Frucht H, Coy DH, Jensen RT.

Mol Pharmacol. 1993 May;43(5):762-74.

PMID:
7684815
[PubMed - indexed for MEDLINE]
15.

[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation.

Bakker WH, Albert R, Bruns C, Breeman WA, Hofland LJ, Marbach P, Pless J, Pralet D, Stolz B, Koper JW, et al.

Life Sci. 1991;49(22):1583-91.

PMID:
1658515
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk